Among seven new medicines recommended for approval by the EMA's human medicine advisory committee at its latest meeting is ...

The FDA has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for people with severe asthma.

The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance treatment for severe ...

The FDA approved depemokimab as an add-on maintenance treatment in patients aged at least 12 years with severe asthma and an ...

With a fresh endorsement from the FDA, the last of five major drug approvals has fallen into place for GSK in 2025. | Tuesday ...

The U.S. health regulator has approved GSK's add-on treatment for severe asthma, offering a less frequently dosed option, but ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

While yoga is essentially a physical act, it is more about the science of enlivening the body, mind, and breath in perfect ...

Due to eczema, asthma and allergies being so closely connected, coordinated care plays a critical role in long-term outcomes. Allergists are uniquely trained to manage these conditions together rather ...

Vermont has one of the highest rates of pediatric asthma in the country — one analysis found that in Vermont, 8.3% of people under the age of 17 have asthma, according to 2023-24 data from the U.S.

December 16 is National Chocolate-Covered Anything Day, which is either a celebration of culinary creativity or an excuse to ...